Practice Guidelines for the Use of rHuG-CSF in an Oncology Setting
作者： Santosh Saraf , Howard Ozer
DOI: 10.1007/978-3-0348-0218-5_7
关键词: Febrile neutropenia 、 Hematopoietic stem cell 、 Cancer 、 Acute lymphocytic leukemia 、 Internal medicine 、 Bone marrow 、 Oncology 、 Clinical Oncology 、 Medicine 、 Transplantation 、 Chemotherapy
摘要: The United States Food and Drug Administration (US FDA) first approved recombinant human granulocyte colony-stimulating factor (rHuG-CSF) in 1991 for very broad indication to treat patients with cancer undergoing myelotoxic chemotherapy. Recombinant granulocyte-macrophage (rHuGM-CSF) was also use bone marrow stem cell transplantation; however, the two drugs were often used interchangeably clinic subsequent guidelines developed by American Society of Clinical Oncology (ASCO) National Comprehensive Cancer Network (NCCN).
springer.com
sci-hub.st 参考文章(258)
K Welte, A Reiter, K Mempel, M Pfetsch, G Schwab, M Schrappe, H Riehm, A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group. Blood. ,vol. 87, pp. 3143- 3150 ,(1996) , 10.1182/BLOOD.V87.8.3143.BLOODJOURNAL8783143
Vito Michele Lauta, Massimo Magagnoli, Luciano Guardigni, Sante Tura, Pier Luigi Zinzani, Monica Bocchia, Brunangelo Falini, Patrizio Mazza, Alfonso Zaccaria, Patrizia Gentilini, Filippo Gherlinzoni, Amalia De Renzo, Sergio Storti, Pier Paolo Fattori, Ettore Volpe, Giuseppe Leone, Francesco Zaja, Maurizio Tabanelli, Luciano Moretti, Enzo Pavone, Maurizio Bendandi, Enrico Aitini, Marco Gobbi, Elderly aggressive-histology non-Hodgkin's lymphoma: First-line VNCOP-B regimen experience on 350 patients Blood. ,vol. 94, pp. 33- 38 ,(1999) , 10.1182/BLOOD.V94.1.33.413K08_33_38
John E. Godwin, Kenneth J. Kopecky, David R. Head, Cheryl L. Willman, Catherine P. Leith, Harry E. Hynes, Stanley P. Balcerzak, Frederick R. Appelbaum, A Double-Blind Placebo-Controlled Trial of Granulocyte Colony-Stimulating Factor in Elderly Patients With Previously Untreated Acute Myeloid Leukemia: A Southwest Oncology Group Study (9031) Blood. ,vol. 91, pp. 3607- 3615 ,(1998) , 10.1182/BLOOD.V91.10.3607
Leo I. Gordon, Mary Young, Edie Weller, Thomas M. Habermann, Jane N. Winter, John Glick, Chirantan Ghosh, Patrick Flynn, Peter A. Cassileth, A phase II trial of 200% ProMACE-CytaBOM in patients with previously untreated aggressive lymphomas: analysis of response, toxicity, and dose intensity. Blood. ,vol. 94, pp. 3307- 3314 ,(1999) , 10.1182/BLOOD.V94.10.3307.422K11_3307_3314
Clara D. Bloomfield, Charles A. Linker, Bayard L. Powell, Stanley R. Frankel, Richard A. Larson, Frederick R. Davey, Richard M. Stone, Philip Schulman, Richard K. Dodge, Edward J. Lee, Stephen L. George, Charles A. Schiffer, A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111. Blood. ,vol. 92, pp. 1556- 1564 ,(1998) , 10.1182/BLOOD.V92.5.1556
Stephanie J. Lee, Edie Weller, Edwin P. Alyea, Jerome Ritz, Robert J. Soiffer, Efficacy and Costs of Granulocyte Colony-Stimulating Factor in Allogeneic T-Cell Depleted Bone Marrow Transplantation Blood. ,vol. 92, pp. 2725- 2729 ,(1998) , 10.1182/BLOOD.V92.8.2725
S A Cannistra, P Groshek, J D Griffin, Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia. Leukemia. ,vol. 3, pp. 328- 334 ,(1989)
K J Neelis, G Wagemaker, Y D Dubbelman, L Qingliang, D L Eaton, G R Thomas, Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells. Experimental Hematology. ,vol. 25, pp. 1084- 1093 ,(1997)
R Ohno, T Naoe, A Kanamaru, M Yoshida, A Hiraoka, T Kobayashi, T Ueda, S Minami, Y Morishima, Y Saito, A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia. Kohseisho Leukemia Study Group [see comments] Blood. ,vol. 83, pp. 2086- 2092 ,(1994) , 10.1182/BLOOD.V83.8.2086.BLOODJOURNAL8382086
Goldstone Ah, Tsakona Cp, Khwaja A, Does treatment with haemopoietic growth factors affect the incidence of bacteraemia in adult lymphoma transplant recipients Bone Marrow Transplantation. ,vol. 11, pp. 433- 436 ,(1993)